Drug profile · INN
atezolizumab and hyaluronidase-tqjs
TECENTRIQ HYBREZA
atezolizumab and hyaluronidase-tqjs (TECENTRIQ HYBREZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — atezolizumab and hyaluronidase-tqjs
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
atezolizumab and hyaluronidase-tqjs (TECENTRIQ HYBREZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is atezolizumab and hyaluronidase-tqjs?
atezolizumab and hyaluronidase-tqjs (TECENTRIQ HYBREZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for atezolizumab and hyaluronidase-tqjs?
TECENTRIQ HYBREZA is a marketed brand name for atezolizumab and hyaluronidase-tqjs. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of atezolizumab and hyaluronidase-tqjs?
atezolizumab and hyaluronidase-tqjs has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.